Periodic Fever Syndrome Market, By Product Type, By Treatment, By Distribution, By Age Group, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

Description

REPORT HIGHLIGHT

Periodic Fever Syndrome Market size was valued at USD 620.90 million in 2023, expanding at a CAGR of 4.80% from 2024 to 2032.

The Periodic Fever Syndrome market focuses on treatments for a group of rare autoinflammatory disorders characterized by recurrent episodes of fever and inflammation, including Familial Mediterranean Fever (FMF), TNF receptor-associated periodic syndrome (TRAPS), and Hyper-IgD syndrome (HIDS). The market is driven by advances in genetic research, which help in early diagnosis and personalized treatment options. Key therapeutic approaches include biologics, such as interleukin-1 inhibitors and TNF inhibitors, offering relief from symptoms and reducing flare-ups. Increased awareness among healthcare professionals and rising patient support initiatives also support market growth. Major players include Novartis, Sobi, and Pfizer, contributing to drug development and clinical trials aimed at addressing these disorders more effectively.

Periodic Fever Syndrome Market- Market Dynamics

Growing Prevalence of Genetic Disorders Leading the Need for Periodic Fever Syndrome

The growing prevalence of genetic disorders is driving an increased demand for effective treatments for conditions like Periodic Fever Syndrome (PFS). As more individuals are diagnosed with genetic mutations linked to autoinflammatory diseases, such as familial Mediterranean fever, hyperimmunoglobulin D syndrome, and TNF receptor-associated periodic syndrome (TRAPS), the need for specialized medical interventions has escalated. Periodic Fever Syndrome, characterized by recurrent fevers and systemic inflammation, can significantly impact patients' quality of life if left untreated. This rise in genetic disorder cases has heightened awareness among healthcare professionals and researchers, pushing for advanced diagnostic tools and therapies to address the unique challenges posed by PFS. According to the World Health Organization, an estimated 240,000 newborns die worldwide within 28 days of birth every year due to congenital disorders. Congenital disorders cause a further 170,000 deaths of children between the ages of 1 month and 5 years. Consequently, the pharmaceutical and biotechnology sectors are working towards developing innovative treatments to manage and alleviate the symptoms associated with these conditions, aiming to improve patient outcomes and reduce the overall disease burden.

Periodic Fever Syndrome Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.80% over the forecast period (2024-2032)

Based on product type segmentation, Hereditary Periodic Fever Syndromes was predicted to show maximum market share in the year 2023

Based on treatment segmentation, Medications was the leading type in 2023

Based on distribution segmentation, Hospital Pharmacies was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Periodic Fever Syndrome Market- Segmentation Analysis:

The Global Periodic Fever Syndrome Market is segmented on the basis of Product Type, Treatment, Distribution, Age Group, and Region.

The market is divided into two categories based on product type: Hereditary Periodic Fever Syndromes, and Acquired Periodic Fever Syndromes. Increased awareness among healthcare professionals and patients has led to higher diagnosis rates. With better diagnostic tools, including genetic testing, more individuals are being identified with HPFS. The development of advanced therapeutic options, particularly biologics like interleukin (IL)-1 inhibitors (e.g., anakinra and canakinumab), has improved treatment outcomes. These innovative treatments offer more effective symptom management, leading to higher adoption.

The market is divided into four categories based on treatment: Medications, Gene Therapy, Symptomatic Treatment, and Other Emerging Therapies. Gene therapy offers the potential for targeted treatments that address the underlying genetic causes of PFS. Since many PFS conditions are caused by specific genetic mutations, gene therapy can directly correct these mutations or modulate the expression of the genes involved. Overall, the combination of targeted treatment potential, technological advancements and supportive research and regulatory environments contribute to the high market share of gene therapy in the Periodic Fever Syndrome market.

Periodic Fever Syndrome Market- Geographical Insights

The Periodic Fever Syndrome market in North America is experiencing notable growth, driven by an increasing awareness of rare genetic conditions, advancements in diagnostic tools, and improved treatment options. The United States dominates the market due to a well-established healthcare infrastructure, the presence of major pharmaceutical companies, and a growing patient population benefiting from advanced therapies. Canada also plays a key role, with expanding research initiatives and rising investment in rare disease treatments. Regulatory support from the U.S. Food and Drug Administration (FDA) and Health Canada has facilitated the approval of new treatments, further accelerating market growth in the region.

Periodic Fever Syndrome Market- Competitive Landscape:

The Periodic Fever Syndrome (PFS) market is characterized by the presence of key pharmaceutical companies focusing on rare diseases and orphan drugs. Major players include Novartis, Swedish Orphan Biovitrum (Sobi), and Regeneron Pharmaceuticals. Novartis, through its biologic therapy Ilaris (canakinumab), holds a significant market share by treating a variety of PFS subtypes, including Cryopyrin-Associated Periodic Syndromes (CAPS). Sobi, with its strong emphasis on immunology and rare disease therapies, also plays a crucial role in addressing PFS with its product Kineret (anakinra). Regeneron, known for its work in inflammatory diseases, offers Dupixent (dupilumab), which can be explored for PFS. The market is further bolstered by smaller biopharmaceutical companies focusing on niche treatments, with ongoing research and development for novel therapies. Competition is driven by innovation, efficacy, and access to orphan drug designations, creating a dynamic environment in this rare disease market.

Recent Developments:

In June 2020, Researchers at the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, discovered clues to the possible cause of recurring, non-contagious fevers and sores that affect only children. Several genes have been implicated with the syndrome, known as PFAPA syndrome which could lead to new treatments.

In September 2020, Novartis announced that the US Food and Drug Administration (FDA) has granted three simultaneous approvals for the expanded use of Ilaris (canakinumab) to treat three rare and distinct types of Periodic Fever Syndromes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERIODIC FEVER SYNDROME MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Novartis AG
Swedish Orphan Biovitrum AB (Sobi)
Regeneron Pharmaceuticals, Inc.
Pfizer Inc.
Horizon Therapeutics plc
Takeda Pharmaceutical Company Ltd.
AbbVie Inc.
Eli Lilly and Company
Amgen Inc.
Sanofi S.A.
Others

GLOBAL PERIODIC FEVER SYNDROME MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

Hereditary Periodic Fever Syndromes
Familial Mediterranean Fever (FMF)
Hyperimmunoglobulinemia D Syndrome (HIDS)
Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS)
Acquired Periodic Fever Syndromes
Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA)
Other Non-Hereditary Periodic Fever Syndromes

GLOBAL PERIODIC FEVER SYNDROME MARKET, BY TREATMENT- MARKET ANALYSIS, 2019 - 2032

Medications
Gene Therapy
Symptomatic Treatment
Other Emerging Therapies

GLOBAL PERIODIC FEVER SYNDROME MARKET, BY DISTRIBUTION- MARKET ANALYSIS, 2019 - 2032

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Specialty Clinics

GLOBAL PERIODIC FEVER SYNDROME MARKET, BY AGE GROUP - MARKET ANALYSIS, 2019 - 2032

Pediatric Patients
Adult Patients

GLOBAL PERIODIC FEVER SYNDROME MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV3857

1. Periodic Fever Syndrome Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Periodic Fever Syndrome Market Snippet by Product Type
- 2.1.2. Periodic Fever Syndrome Market Snippet by Treatment
- 2.1.3. Periodic Fever Syndrome Market Snippet by Distribution
- 2.1.4. Periodic Fever Syndrome Market Snippet by Age Group
- 2.1.5. Periodic Fever Syndrome Market Snippet by Country
- 2.1.6. Periodic Fever Syndrome Market Snippet by Region
2.2. Competitive Insights

3. Periodic Fever Syndrome Key Market Trends

3.1. Periodic Fever Syndrome Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Periodic Fever Syndrome Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Periodic Fever Syndrome Market Opportunities
3.4. Periodic Fever Syndrome Market Future Trends

4. Periodic Fever Syndrome Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Periodic Fever Syndrome Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Periodic Fever Syndrome Market Landscape

6.1. Periodic Fever Syndrome Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Periodic Fever Syndrome Market - By Product Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2023 & 2032 (%)
- 7.1.2. Hereditary Periodic Fever Syndromes
  - 7.1.2.1. Familial Mediterranean Fever (FMF)
  - 7.1.2.2. Hyperimmunoglobulinemia D Syndrome (HIDS)
  - 7.1.2.3. Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (TRAPS)
- 7.1.3. Acquired Periodic Fever Syndromes
  - 7.1.3.1. Periodic Fever, Aphthous Stomatitis, Pharyngitis, Adenitis (PFAPA)
  - 7.1.3.2. Other Non-Hereditary Periodic Fever Syndromes

8. Periodic Fever Syndrome Market - By Treatment

8.1. Overview
- 8.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
- 8.1.2. Medications
- 8.1.3. Gene Therapy
- 8.1.4. Symptomatic Treatment
- 8.1.5. Other Emerging Therapies

9. Periodic Fever Syndrome Market - By Distribution

9.1. Overview
- 9.1.1. Segment Share Analysis, By Distribution, 2023 & 2032 (%)
- 9.1.2. Hospital Pharmacies
- 9.1.3. Retail Pharmacies
- 9.1.4. Online Pharmacies
- 9.1.5. Specialty Clinics

10. Periodic Fever Syndrome Market - By Age Group

10.1. Overview
- 10.1.1. Segment Share Analysis, By Treatment, 2023 & 2032 (%)
- 10.1.2. Pediatric Patients
- 10.1.3. Adult Patients

11. Periodic Fever Syndrome Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. Periodic Fever Syndrome Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. Periodic Fever Syndrome Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.3.9. Italy
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.9.4. Italy Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.3.9.5. Italy Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.3.9.6. Italy Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.3.10. United Kingdom
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.10.4. United Kingdom Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.3.10.5. United Kingdom Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.3.10.6. United Kingdom Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.3.11. France
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.11.4. France Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.3.11.5. France Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.3.11.6. France Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.3.12. Russia
  - 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.12.3. Russia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Russia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Russia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.3.13. Netherlands
  - 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.13.3. Netherlands Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.3.13.4. Netherlands Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.3.13.5. Netherlands Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.3.15. Poland
  - 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.15.3. Poland Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Poland Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Poland Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.3.16. Rest of Europe
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Rest of the Europe Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Rest of the Europe Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Rest of the Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. Periodic Fever Syndrome Key Manufacturers in Asia Pacific
- 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.5. Asia Pacific Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 11.4.6. Asia Pacific Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.4.7. Asia Pacific Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.4.8. India
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.8.4. India Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.4.8.5. India Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.4.8.6. India Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.4.9. China
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.9.4. China Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.4.9.5. China Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.4.9.6. China Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.4.13. Thailand
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Thailand Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Thailand Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Thailand Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.4.14. Indonesia
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Indonesia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Indonesia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Indonesia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
11.5. Latin America
- 11.5.1. Overview
- 11.5.2. Periodic Fever Syndrome Key Manufacturers in Latin America
- 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. Latin America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.5. Latin America Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 11.5.6. Latin America Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.5.7. Latin America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa
- 11.6.1. Overview
- 11.6.2. Periodic Fever Syndrome Key Manufacturers in Middle East and Africa
- 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.5. Middle East and Africa Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
- 11.6.6. Middle East and Africa Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
- 11.6.7. Middle East and Africa Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Treatment, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Distribution, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Periodic Fever Syndrome Industry

12.1. Competitive Dashboard
12.2. Company Profiles
- 12.2.1. Novartis AG
- 12.2.2. Swedish Orphan Biovitrum AB (Sobi)
- 12.2.3. Regeneron Pharmaceuticals, Inc.
- 12.2.4. Pfizer Inc.
- 12.2.5. Horizon Therapeutics plc
- 12.2.6. Takeda Pharmaceutical Company Ltd.
- 12.2.7. AbbVie Inc.
- 12.2.8. Eli Lilly and Company
- 12.2.9. Amgen Inc.
- 12.2.10. Sanofi S.A.
- 12.2.11. Others

13. 360 Degree Analyst View

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us